Disease-modifying anti-rheumatic drugs (DMARDs) slow the advancement of rheumatoid arthritis. They reduce inflammation and joint damage. Taking DMARDs may lead to a remission. Common DMARDs include methotrexate (Rheumatrex), sulfasalazine (azulfidine) and lefluenomide (Avara).
On November 19th, I went to the local hospital outpatient infusion clinic to receive the first dose of Rituxan® (rituximab). This Thursday I go back for the second dose which will complete one round of treatment. Rituxan in combination with methotrexate is indicated for the treatment of adult patients with moderately to severely…